Deficits in plasma oestradiol measurement in studies and management of breast cancer
Mitch Dowsett(Institute of Cancer Research), Elizabeth Folkerd(Royal Marsden Hospital)
Cited by 82
Related Papers
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Mechanisms of tamoxifen resistance
|Endocrine Related Cancer|2004|652
Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
|Journal of Clinical Oncology|2008|464
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425